CVC and GBL secured a 74.3% stake in Italian pharmaceutical firm Recordati via a €53-a-share bid valued at €11 billion, exceeding their minimum acceptance threshold. They remain short of the 90% delis
reuters · 2026-10-23 10:37
Recordati's board voted 6-4 to accept CVC and GBL's €10.7 billion takeover offer as fair, despite four independent directors dissenting over valuation concerns. The proposed delisting aligns with broa
reuters · 2026-07-15 15:51
Private equity firms CVC and GBL launched a €10.7 billion cash bid to take over Italian pharmaceutical group Recordati, offering €51.29 per share. The controlling shareholder has agreed to tender its
reuters · 2026-05-21 22:41
ChemBrief